Drugs / Probiotic
Trials 9
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03574051 | May 2018 → May 2020 | — | First Affiliated Hospital of Harbin Medical University | Unknown | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT04165551 | Oct 2019 → Sep 2020 | group B streptococcal infection | Biosearch S.A. | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04119011 | Oct 2019 → Mar 2020 | primary dysmenorrhea | National University of Malaysia | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07413744 | Aug 2026 → Mar 2029 expected | Alzheimer disease | University of Wisconsin, Madison | Not yet recruiting | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02752594 | Apr 2015 | dental caries | Sharda University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01765998 | Feb 2013 → Feb 2014 | Crohn disease | The Baruch Padeh Medical Center, Poriya | Unknown | No outcome recorded |
| Phase not applicable3 trials · 1 met primary | ||||||
| — | NCT07331987 | Jun → Dec 2026 expected | mixed anxiety and depressive disorder | Moon (Guangzhou) Biotechnology Co., Ltd. | Recruiting | No outcome recorded |
| — | NCT05548361 | Apr 2022 → Dec 2024 | periodontitis | Cukurova University | Completed | No outcome recorded |
| — | NCT00159523 | Dec 2003 → Sep 2007 | asthma, atopic eczema, perennial allergic rhinitis | Norwegian University of Science and Technology | Completed | Met primary |
| Comparator or background therapy3 trials | ||||||
| Phase 3 | NCT03266913 Comparator | Aug → Oct 2017 | hyperbilirubinemia | Hormozgan University of Medical Sciences | Unknown | No outcome recorded |
| Phase 4 | NCT05160350 Comparator | Apr → Oct 2021 | epilepsy | Mazandaran University of Medical Sciences | Completed | No outcome recorded |
| — | NCT07233382 Comparator | Dec 2025 → May 2026 overdue | necrotizing enterocolitis | Hayatabad Medical Complex | Not yet recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 15 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Probiotic | “Drug: Probiotic” NCT03266913 ↗ |
| Known as | L. acidophilus La-5 | “In a randomized, double-blind trial, women received probiotic milk or placebo from 36 weeks of gestation up to 3 months postnatally while breast-feeding. The probiotic milk...” PMID 25782657 ↗ Aug 2015 |
| Action | Inhibit | “the ability of a battery of Lactobacillus strains to inhibit the growth of S. agalactiae” NCT04165551 ↗ |
| Modality | Other / unclassified | “The probiotic bacteria included Lactobacillus rhamnosus GG (LGG), Bifidobacterium animalis subsp. lactis Bb-12 and Lactobacillus acidophilus La-5.” PMID 28837002 ↗ Aug 2017 |
| Route | Oral | “a subset of 278 pregnant mothers was randomized to drink milk with or without probiotic bacteria during and after pregnancy” PMID 33240830 ↗ Nov 2020 |